Sven Lindemann

USPTO Granted Patents = 5 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12209136 - ADAMTS binding immunoglobulins (2025-01-28),

2. 11813307 - Polypeptides binding ADAMTS5, MMP13 and aggrecan (2023-11-14),

3. 11261260 - ADAMTS binding immunoglobulins (2022-03-01),

4. 9750784 - Intraarticular application of pepstatin in the case of arthrosis (2017-09-05),

5. 9656949 - Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis (2017-05-23),

Title: Sven Lindemann - Innovative Inventor from Darmstadt

Introduction: Sven Lindemann is a renowned inventor hailing from Darmstadt, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Sven Lindemann holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Sven Lindemann has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Sven Lindemann has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Sven Lindemann's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the global technology landscape.

This text is generated by artificial intelligence and may not be accurate.